The role of aberrant cholesterol metabolism in prostate cancer cells is further supported by a study showing increased expression of the high-density lipoprotein-cholesterol scavenger receptor B1 (SR-B1) in primary and mCRPC cells [462]. The gene discussed is SCARB1; the disease is prostate carcinoma.